R A Ross
Overview
Explore the profile of R A Ross including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
3533
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Velasco E, Florido A, Flores A, Senabre E, Gomez-Gomez A, Torres A, et al.
Nat Commun
. 2022 Jul;
13(1):4374.
PMID: 35902577
Exposure to traumatic stress can lead to fear dysregulation, which has been associated with posttraumatic stress disorder (PTSD). Previous work showed that a polymorphism in the PACAP-PAC1R (pituitary adenylate cyclase-activating...
2.
Bolognini D, Ross R
Clin Pharmacol Ther
. 2015 Mar;
97(6):568-70.
PMID: 25761845
The medical use of cannabis has an intricate therapeutic history that finds its roots in ancient China (∼2700 BC). The main psychoactive component of cannabis, Δ(9) -tetrahydrocannabinol (Δ(9) -THC), was...
3.
Ross R, Selwood P
J R Nav Med Serv
. 2014 Oct;
100(2):210-4.
PMID: 25335319
In this article a snapshot of casualty presentations to the UK Role 3 hospital in Camp Bastion, Afghanistan, will be briefly described. The observations allow reflection on the advances and...
4.
Alexander S, Benson H, Faccenda E, Pawson A, Sharman J, McGrath J, et al.
Br J Pharmacol
. 2014 Feb;
170(8):1449-58.
PMID: 24528237
The Concise Guide to PHARMACOLOGY 2013/14 provides concise overviews of the key properties of over 2000 human drug targets with their pharmacology, plus links to an open access knowledgebase of...
5.
Diaz-Arteaga A, Vazquez M, Vazquez-Martinez R, Pulido M, Suarez J, Velasquez D, et al.
Diabetes Obes Metab
. 2011 Oct;
14(3):234-43.
PMID: 21981246
Aims: Cannabinoids are known to control energy homeostasis. Atypical cannabinoids produce pharmacological effects via unidentified targets. We sought to investigate whether the atypical cannabinoid O-1602 controls food intake and body...
6.
Whyte L, Ford L, Ridge S, Cameron G, Rogers M, Ross R
Br J Pharmacol
. 2011 Jun;
165(8):2584-97.
PMID: 21649637
Background And Purpose: Both CB(1) and CB(2) cannabinoid receptors have been shown to play a role in bone metabolism. Crucially, previous studies have focussed on the effects of cannabinoid ligands...
7.
8.
Pertwee R, Howlett A, Abood M, Alexander S, Di Marzo V, Elphick M, et al.
Pharmacol Rev
. 2010 Nov;
62(4):588-631.
PMID: 21079038
There are at least two types of cannabinoid receptors (CB(1) and CB(2)). Ligands activating these G protein-coupled receptors (GPCRs) include the phytocannabinoid Δ(9)-tetrahydrocannabinol, numerous synthetic compounds, and endogenous compounds known...
9.
Ross R, Rossetti L, Lam T, Schwartz G
Am J Physiol Endocrinol Metab
. 2010 Jul;
299(4):E633-9.
PMID: 20647558
Our objective was to investigate whether the direct bilateral infusion of the monounsaturated fatty acid (MUFA) oleic acid (OA) within the mediobasal hypothalamus (MBH) is sufficient to reproduce the effect...
10.
Thors L, Burston J, Alter B, McKinney M, Cravatt B, Ross R, et al.
Br J Pharmacol
. 2010 Jul;
160(3):549-60.
PMID: 20590565
Background And Purpose: Inhibitors of fatty acid amide hydrolase (FAAH), the enzyme responsible for the metabolism of the endogenous cannabinoid (CB) receptor ligand anandamide (AEA), are effective in a number...